Health

Global Drug Delivery Systems (DDS) Market Transforms Amid New Pharma Demands

FRAMINGHAM, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Alira Health today released its 2025 Global Drug Delivery System Trends Report,…

1 month ago

GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies

The formal safety review of Cohort 3 (5ug/kg/day) has been successfully completed with no safety or tolerability issues observed, allowing…

1 month ago

CathWorks Announces Key Events for TCT 2025

The CathWorks FFRangio® System to be Center Stage, Featured in Multiple Scientific Sessions, Live Cases and a Primetime Academic Satellite…

1 month ago

Cambrex Unveils $120 Million Investment to Expand API Manufacturing and Strengthen U.S. Drug Supply Resilience

EAST RUTHERFORD, N.J., Oct. 22, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced a…

1 month ago

Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting

SOUTH SAN FRANCISCO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered…

1 month ago

BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio

MELVILLE, N.Y., Oct. 22, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine…

1 month ago

JOY GROUP Completes Acquisition of Italian Dermatological Hair Care Brand Foltne

SHANGHAI, Oct. 21, 2025 /PRNewswire/ -- China's leading multi-brand beauty group JOY GROUP (Shanghai Juyi Cosmetics Co., Ltd.) has announced the completion…

1 month ago

Virtuosi 2.0 – Unleashed

The Next Generation of BioPharma Education for the Advanced Manufacturing Era ALEXANDRIA, Va., Oct. 21, 2025 /PRNewswire/ -- Quality Executive…

1 month ago

IPSEN – Buy-back programme – Art 5 of MAR – Week 42 – 2025

Aggregated presentation by day and by marketStatement of transactions in own shares from October 13th to October 17th 2025       Name of…

1 month ago

Curia Sterile Drug Product Facility Named Massachusetts Manufacturer of the Year

ALBANY, N.Y., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization,…

1 month ago